Viewing Study NCT00827203


Ignite Creation Date: 2025-12-24 @ 7:13 PM
Ignite Modification Date: 2025-12-26 @ 2:29 PM
Study NCT ID: NCT00827203
Status: SUSPENDED
Last Update Posted: 2009-03-09
First Post: 2009-01-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Sponsor: Synta Pharmaceuticals Corp.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module